Lifestyle Modification and Prevention of Type 2 Diabetes in Overweight Japanese With Impaired Fasting Glucose Levels A Randomized Controlled Trial

被引:215
|
作者
Saito, Toshikazu [1 ]
Watanabe, Makoto [6 ]
Nishida, Junko
Izumi, Tomono
Omura, Masao
Takagi, Toshikazu [3 ]
Fukunaga, Ryuzo [7 ]
Bandai, Yasutsugu [2 ]
Tajima, Naoko [4 ]
Nakamura, Yosikazu [8 ]
Ito, Masaharu [5 ]
机构
[1] Social Insurance Chuo Gen Hosp, Dept Internal Med, Shinjyuku Ku, Tokyo 1690073, Japan
[2] Social Insurance Chuo Gen Hosp, Dept Surg, Tokyo 1690073, Japan
[3] Ikebukuro Hosp, Dept Internal Med, Tokyo, Japan
[4] Jikei Univ, Sch Med, Dept Internal Med, Tokyo, Japan
[5] All Japan Federat Social Insurance Assoc, Tokyo, Japan
[6] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Osaka, Japan
[7] Hoshigaoka Employees Pens Welf Hosp, Dept Strokol, Osaka, Japan
[8] Jichi Med Univ, Dept Publ Hlth, Shimotsuke, Tochigi, Japan
关键词
PREVALENCE; INTERVENTION; TOLERANCE; IGT;
D O I
10.1001/archinternmed.2011.275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous studies demonstrated that intensive lifestyle modification can prevent type 2 diabetes mellitus among those with impaired glucose tolerance, but similar beneficial results have not been proved among those with impaired fasting glucose levels. We investigated the efficacy of lifestyle modification on type 2 diabetes incidence among those with impaired fasting glucose levels. Methods: The present study was an unmasked, multicenter, randomized, controlled trial. A total of 641 overweight Japanese (aged 30-60 years) with impaired fasting glucose levels were recruited nationwide in Japan and randomly assigned to a frequent intervention group (n=311) or a control group (n=330). For 36 months after randomization, the frequent intervention group received individual instructions and follow-up support for lifestyle modification from the medical staff 9 times. The control group received similar individual instructions 4 times at 12-month intervals during the same period. The primary outcome was type 2 diabetes incidence in annual 75-g oral glucose tolerance tests, diagnosed according to World Health Organization criteria. Results: There were no significant differences between the allocation groups in baseline characteristics and dropout rates. Estimated cumulative incidences of type 2 diabetes were 12.2% in the frequent intervention group and 16.6% in the control group. Overall, the adjusted hazard ratio in the frequent intervention group was 0.56 (95% confidence interval, 0.36-0.87). In the post hoc subgroup analyses, the hazard ratio reduced to 0.41 (95% confidence interval, 0.24-0.69) among participants with impaired glucose tolerance at baseline, and to 0.24 (0.12-0.48) among those with baseline hemoglobin A(1c) levels of 5.6% or more (the Japan Diabetes Society method). Such risk reduction was not observed among those with isolated impaired fasting glucose findings or baseline hemoglobin A(1c) levels of less than 5.6%. Conclusions: Lifestyle modifications can prevent type 2 diabetes among overweight Japanese with impaired fasting glucose levels. In addition, identifying individuals with more deteriorated glycemic status by using 75-g oral glucose tolerance test findings or, especially, measurement of hemoglobin A(1c) levels, could enhance the efficacy of lifestyle modifications.
引用
收藏
页码:1352 / 1360
页数:9
相关论文
共 50 条
  • [1] Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea
    Lee, Jin-Hee
    Chon, Suk
    Cha, Seon-Ah
    Lim, Sun-Young
    Kim, Kook-Rye
    Yun, Jae-Seung
    Rhee, Sang Youl
    Yoon, Kun-Ho
    Ahn, Yu-Bae
    Woo, Jeong-Taek
    Ko, Seung-Hyun
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (02): : 382 - +
  • [2] A cluster-randomized controlled trial to study the effectiveness of a protocol-based lifestyle program to prevent type 2 diabetes in people with impaired fasting glucose
    Arlette E Hesselink
    Henk JG Bilo
    Ruud Jonkers
    Marloes Martens
    Inge de Weerdt
    Guy EH Rutten
    [J]. BMC Family Practice, 14
  • [3] A cluster-randomized controlled trial to study the effectiveness of a protocol-based lifestyle program to prevent type 2 diabetes in people with impaired fasting glucose
    Hesselink, Arlette E.
    Bilo, Henk J. G.
    Jonkers, Ruud
    Martens, Marloes
    de Weerdt, Inge
    Rutten, Guy E. H.
    [J]. BMC FAMILY PRACTICE, 2013, 14
  • [4] Effects of a lifestyle program in subjects with Impaired Fasting Glucose, a pragmatic cluster-randomized controlled trial
    Hesselink, Arlette E.
    Rutten, Guy E. H.
    Slootmaker, Sander M.
    de Weerdt, Inge
    Raaijmakers, Lieke G. M.
    Jonkers, Ruud
    Martens, Marloes K.
    Bilo, Henk J. G.
    [J]. BMC FAMILY PRACTICE, 2015, 16
  • [5] Lifestyle Intervention With or Without Lay Volunteers to Prevent Type 2 Diabetes in People With Impaired Fasting Glucose and/or Nondiabetic Hyperglycemia A Randomized Clinical Trial
    Sampson, Michael
    Clark, Allan
    Bachmann, Max
    Garner, Nikki
    Irvine, Lisa
    Howe, Amanda
    Greaves, Colin
    Auckland, Sara
    Smith, Jane
    Turner, Jeremy
    Rea, Dave
    Rayman, Gerry
    Dhatariya, Ketan
    John, W. Garry
    Barton, Garry
    Usher, Rebecca
    Ferns, Clare
    Pascale, Melanie
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (02) : 168 - 178
  • [6] Effects of a lifestyle program in subjects with Impaired Fasting Glucose, a pragmatic cluster-randomized controlled trial
    Arlette E. Hesselink
    Guy E. H. Rutten
    Sander M. Slootmaker
    Inge de Weerdt
    Lieke G.M. Raaijmakers
    Ruud Jonkers
    Marloes K. Martens
    Henk J. G. Bilo
    [J]. BMC Family Practice, 16
  • [7] The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial
    Grey, Andrew
    Bolland, Mark
    Fenwick, Sheryl
    Horne, Anne
    Gamble, Greg
    Drury, Paul L.
    Reid, Ian R.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 170 (02) : 255 - 262
  • [8] A Systematic Review of Lifestyle Modification and Glucose Intolerance in the Prevention of Type 2 Diabetes
    Thomas, G. Neil
    Jiang, Chao Q.
    Taheri, Shahrad
    Xiao, Zheng H.
    Tomlinson, Brian
    Cheung, Bernard M. Y.
    Lam, Tai H.
    Barnett, Anthony H.
    Cheng, Kar K.
    [J]. CURRENT DIABETES REVIEWS, 2010, 6 (06) : 378 - 387
  • [9] THE ROLE OF LIFESTYLE MODIFICATION IN PREVENTING TYPE 2 DIABETES MELLITUS WITH IMPAIRED GLUCOSE HOMEOSTASIS
    Shishko, E.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A132 - A132
  • [10] The role of lifestyle modification in preventing type 2 diabetes in subjects with impaired glucose homeostasis
    Shishko, E.
    Mokbort, T.
    Garmaev, D.
    [J]. DIABETOLOGIA, 2006, 49 : 457 - 458